Clinical Trials Directory

Trials / Unknown

UnknownNCT00973336

Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?

Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Successful Surgery in Patients Without Osteoporosis?

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary Hyperparathyroidism (pHPT) increases bone turnover and resorption and thus calcium efflux out of bone. After successful surgical treatment of pHPT, bone takes up calcium again which may result in secondary hyperparathyroidism or even "hungry bone syndrome". Until today there are no studies about this problem helping to develop recommendations or guidelines how to prevent these symptoms. Study hypothesis: Calcium and vitamin D intake after surgery for PHPT protects the bone by keeping PTH in the normal range (less secondary, reactive hyperparathyroidism), prevents hungry bone- syndrome and improve bone-turnover markers (osteoporosis protection).

Conditions

Interventions

TypeNameDescription
DRUGCalcium and vitamin D1000mg calcium per day 800 IE vitamin D per day

Timeline

Start date
2009-09-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2009-09-09
Last updated
2016-03-16

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00973336. Inclusion in this directory is not an endorsement.